Appili Therapeutics Inc.
APLIF
$0.01
$0.00-1.27%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -754.40K | -683.60K | -718.10K | -903.20K | 158.90K |
| Total Depreciation and Amortization | 900.00 | 0.00 | 2.40K | 2.60K | 2.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 330.30K | 192.40K | -73.00K | 124.50K | 699.40K |
| Change in Net Operating Assets | 213.30K | 290.50K | 237.40K | 771.40K | -139.90K |
| Cash from Operations | -209.90K | -200.70K | -551.30K | -4.60K | 720.60K |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | 2.60K | -600.00 | -30.10K | -29.30K | -44.90K |
| Issuance of Common Stock | 100.00K | 177.50K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 18.80K | -27.40K | -47.30K | -13.00K | -16.40K |
| Cash from Financing | 87.30K | 107.20K | -56.20K | -30.60K | -42.60K |
| Foreign Exchange rate Adjustments | -1.60K | -4.00K | 43.90K | -39.40K | 48.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -124.20K | -97.50K | -563.70K | -74.60K | 726.10K |